Search
Patexia Research
Case number 1:19-cv-01488

Janssen Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al > Documents

Date Field Doc. No.Description (Pages)
Sep 30, 2019 7 Patent/Trademark Report to Commissioner (1)
Sep 30, 2019 7 Notice of Dismissal (1)
Sep 30, 2019 7 Main Document (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,439,906 B2. (Attachments: # (1) Notice of Dismissal)(fms)
Sep 27, 2019 N/A Terminated Case (0)
Docket Text: CASE CLOSED per D.I. [6]. (fms)
Sep 27, 2019 6 Notice of Voluntary Dismissal (1)
Docket Text: NOTICE of Voluntary Dismissal by Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. as to Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Mylan Institutional LLC (without prejudice) (Blumenfeld, Jack)
Aug 14, 2019 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nmg)
Aug 9, 2019 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Mylan Institutional LLC on 8/9/2019; Mylan Laboratories Limited on 8/9/2019; Mylan Pharmaceuticals Inc. on 8/9/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sam)
Aug 9, 2019 1 Complaint (15)
Aug 9, 2019 1 Exhibit A (25)
Aug 9, 2019 1 Civil Cover Sheet (1)
Aug 9, 2019 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam)
Aug 9, 2019 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: July 2, 2019. Date of Expiration of Patent: January 26, 2031.Thirty Month Stay Deadline: 1/2/2022. (sam)
Aug 9, 2019 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,439,906 B2. (sam)
Aug 9, 2019 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. (sam)
Aug 9, 2019 1 Main Document (15)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Institutional LLC, Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2705242.) - filed by Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(sam)
Aug 9, 2019 1 Complaint* (1)
Menu